Product Code: 978-1-68038-901-2
Ophthalmic Devices Market Growth & Trends:
The global ophthalmic devices market size is estimated to reach USD 29.80 billion by 2030, expanding at a CAGR of 7.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising geriatric population is presumed to propel the need for ophthalmic devices due to the high risk of developing chronic eye disorders. According to the National Institute on Aging (NIA), the geriatric population will be about 72 million individuals by 2030. The rising prevalence of eye disorders, such as macular degeneration, cataracts, diabetic retinopathy, and glaucoma, is also boosting product demand. As per the WHO, glaucoma accounts for 4.5 million cases of blindness globally. In the United States, glaucoma is termed the "Silent Thief of Sight," which is the second-leading cause of blindness.
The market growth can also be attributed to technological advancements, such as the development of intraocular lenses, fundus cameras, and OCT devices. Furthermore, the increasing involvement of market players in expanding treatment solutions through strategic alliances is expected to present this market with a potential growth platform. Approximately 10% of the people suffering from eye disorders are expected to experience loss of vision despite the proper treatment, as per the statistics of the WHO, driving the clinical urgency to incorporate highly advanced ophthalmic devices. Furthermore, rising demand for minimally invasive and complication-free operative surgeries is expected to boost product demand. Due to the COVID-19 pandemic, the majority of the population's screen time was increased, resulting in increased cases of various eye issues, which will support market growth over the forecast period.
Ophthalmic Devices Market Report Highlights:
- Based on product, The optical coherence tomography (OCT) segment dominated the market and accounted for the largest revenue share of 23.3% in 2024.
- The cataract segment dominated the market and accounted for the largest revenue share of 41.5% in 2024.
- The ophthalmoscopes segment is anticipated to witness a significant growth rate of 8.1% over the forecast period.
- The cataract segment dominated the market and accounted for the largest revenue share of 41.5% in 2024.
- This growth can be attributed to the increasing number of patients suffering from cataracts and high product adoption for cataract surgeries
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Ophthalmic Devices Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Ancillary Market Outlook
- 3.2. Pricing Analysis
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.1.1. Rising prevalence of eye disease
- 3.3.1.2. Technological advancements in ophthalmic surgical and diagnostic instruments
- 3.3.1.3. Government initiatives for increasing awareness related to visual impairment
- 3.3.2. Market Restraint Analysis
- 3.3.2.1. Lack of trained ophthalmologists in developing nations
- 3.3.2.2. High cost of devices in developing economies
- 3.3.3. Market Challenge Analysis
- 3.4. Ophthalmic Devices Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Bargaining power of suppliers
- 3.4.1.2. Bargaining power of buyers
- 3.4.1.3. Threat of substitutes
- 3.4.1.4. Threat of new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political & Legal Landscape
- 3.4.2.2. Economic and Social Landscape
- 3.4.2.3. Technological landscape
Chapter 4. Ophthalmic Devices Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Ophthalmic Devices Market: Product Movement Analysis
- 4.3. Ophthalmic Devices Market by Product Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5. Optical Coherence Tomography (OCT)
- 4.5.1. Optical Coherence Tomography (OCT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Fundus Camera
- 4.6.1. Fundus Camera Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7. Perimeters/Visual Field Analyzers
- 4.7.1. Perimeters/Visual Field Analyzers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.8. Autorefractors and Keratometers
- 4.8.1. Autorefractors and Keratometers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.9. Ophthalmic Ultrasound Imaging Systems
- 4.9.1. Ophthalmic Ultrasound Imaging Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.9.2. Ophthalmic A-Scan Ultrasound
- 4.9.2.1. Ophthalmic A-Scan Ultrasound Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.9.3. Ophthalmic B-Scan Ultrasound
- 4.9.3.1. Ophthalmic B-Scan Ultrasound Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.9.4. Ophthalmic Ultrasound Biomicroscopes
- 4.9.4.1. Ophthalmic Ultrasound Biomicroscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.10. Ophthalmic Pachymeters
- 4.10.1. Ophthalmic Pachymeters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.11. Tonometers
- 4.11.1. Tonometers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.12. Slit Lamps
- 4.12.1. Slit Lamps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.13. Phoropters
- 4.13.1. Phoropters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.14. Wavefront Aberrometers
- 4.14.1. Wavefront Aberrometers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.15. Optical Biometry Systems
- 4.15.1. Optical Biometry Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.16. Ophthalmoscopes
- 4.16.1. Ophthalmoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.17. Lensometers
- 4.17.1. Lensometers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.18. Corneal Topography Systems
- 4.18.1. Corneal Topography Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.19. Specular Microscopes
- 4.19.1. Specular Microscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.20. Retinoscopes
- 4.20.1. Retinoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Ophthalmic Devices Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Ophthalmic Devices Market: Application Movement Analysis
- 5.3. Ophthalmic Devices Market by Application Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5. Cataract
- 5.5.1. Cataract Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.2. Vitreo Retinal Disorders
- 5.5.2.1. Vitreo Retinal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.3. Glaucoma
- 5.5.3.1. Glaucoma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.4. Refractive Disorders
- 5.5.4.1. Refractive Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Ophthalmic Devices Market: End use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Ophthalmic Devices Market: End use Movement Analysis
- 6.3. Ophthalmic Devices Market by End use Outlook (Revenue, USD Million)
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5. Hospitals and Eye Clinics
- 6.5.1. Hospitals and Eye Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Academic and Research Laboratory
- 6.6.1. Academic and Research Laboratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Others
- 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Ophthalmic Devices Market: Regional Estimates & Trend Analysis
- 7.1. Regional Dashboard
- 7.2. Regional Ophthalmic Devices Market: Regional Movement Analysis
- 7.3. Ophthalmic Devices Market: Regional Estimates & Trend Analysis by Product & End use
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.5. North America
- 7.5.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. U.S.
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Reimbursement Scenario
- 7.5.2.5. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.3. Canada
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Reimbursement Scenario
- 7.5.3.5. Canada market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.4. Mexico
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. Reimbursement Scenario
- 7.5.4.5. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6. Europe
- 7.6.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. UK
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Reimbursement Scenario
- 7.6.2.5. UK market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.3. Germany
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Reimbursement Scenario
- 7.6.3.5. Germany market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.4. France
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. Reimbursement Scenario
- 7.6.4.5. France market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.5. Italy
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Reimbursement Scenario
- 7.6.5.5. Italy market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.6. Spain
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Competitive Scenario
- 7.6.6.3. Regulatory Framework
- 7.6.6.4. Reimbursement Scenario
- 7.6.6.5. Spain market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.7. Denmark
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Competitive Scenario
- 7.6.7.3. Regulatory Framework
- 7.6.7.4. Reimbursement Scenario
- 7.6.7.5. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.8. Sweden
- 7.6.8.1. Key Country Dynamics
- 7.6.8.2. Competitive Scenario
- 7.6.8.3. Regulatory Framework
- 7.6.8.4. Reimbursement Scenario
- 7.6.8.5. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.9. Norway
- 7.6.9.1. Key Country Dynamics
- 7.6.9.2. Competitive Scenario
- 7.6.9.3. Regulatory Framework
- 7.6.9.4. Reimbursement Scenario
- 7.6.9.5. Norway market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.2. Japan
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. Reimbursement Scenario
- 7.7.2.5. Japan market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.3. China
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Reimbursement Scenario
- 7.7.3.5. China market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.4. India
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. Reimbursement Scenario
- 7.7.4.5. India market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory Framework
- 7.7.5.4. Reimbursement Scenario
- 7.7.5.5. South Korean market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.6. Australia
- 7.7.6.1. Key Country Dynamics
- 7.7.6.2. Competitive Scenario
- 7.7.6.3. Regulatory Framework
- 7.7.6.4. Reimbursement Scenario
- 7.7.6.5. Australia market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.7. Thailand
- 7.7.7.1. Key Country Dynamics
- 7.7.7.2. Competitive Scenario
- 7.7.7.3. Regulatory Framework
- 7.7.7.4. Reimbursement Scenario
- 7.7.7.5. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.2. Brazil
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Competitive Scenario
- 7.8.2.3. Regulatory Framework
- 7.8.2.4. Reimbursement Scenario
- 7.8.2.5. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
- 7.8.3. Argentina
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Competitive Scenario
- 7.8.3.3. Regulatory Framework
- 7.8.3.4. Reimbursement Scenario
- 7.8.3.5. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
- 7.9. Middle East & Africa
- 7.9.1. Middle East & Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9.2. South Africa
- 7.9.2.1. Key Country Dynamics
- 7.9.2.2. Competitive Scenario
- 7.9.2.3. Regulatory Framework
- 7.9.2.4. Reimbursement Scenario
- 7.9.2.5. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
- 7.9.3. Saudi Arabia
- 7.9.3.1. Key Country Dynamics
- 7.9.3.2. Competitive Scenario
- 7.9.3.3. Regulatory Framework
- 7.9.3.4. Reimbursement Scenario
- 7.9.3.5. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
- 7.9.4. UAE
- 7.9.4.1. Key Country Dynamics
- 7.9.4.2. Competitive Scenario
- 7.9.4.3. Regulatory Framework
- 7.9.4.4. Reimbursement Scenario
- 7.9.4.5. UAE market estimates and forecast, 2018 - 2030 (USD Million)
- 7.9.5. Kuwait
- 7.9.5.1. Key Country Dynamics
- 7.9.5.2. Competitive Scenario
- 7.9.5.3. Regulatory Framework
- 7.9.5.4. Reimbursement Scenario
- 7.9.5.5. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Market Participant Categorization
- 8.2. Key Company Profiles
- 8.3. Market Share & Position Analysis, 2024
- 8.3.1. Johnson & Johnson Vision Care
- 8.3.1.1. Company Overview
- 8.3.1.2. Financial Performance
- 8.3.1.3. Service Benchmarking
- 8.3.1.4. Strategic Initiatives
- 8.3.2. Alcon Vision LLC
- 8.3.2.1. Company Overview
- 8.3.2.2. Financial Performance
- 8.3.2.3. Service Benchmarking
- 8.3.2.4. Strategic Initiatives
- 8.3.3. Carl Zeiss Meditec AG
- 8.3.3.1. Company Overview
- 8.3.3.2. Financial Performance
- 8.3.3.3. Service Benchmarking
- 8.3.3.4. Strategic Initiatives
- 8.3.4. Bausch & Lomb Incorporated
- 8.3.4.1. Company Overview
- 8.3.4.2. Financial Performance
- 8.3.4.3. Service Benchmarking
- 8.3.4.4. Strategic Initiatives
- 8.3.5. Essilor International S.A
- 8.3.5.1. Company Overview
- 8.3.5.2. Financial Performance
- 8.3.5.3. Service Benchmarking
- 8.3.5.4. Strategic Initiatives
- 8.3.6. Ziemer Ophthalmic Systems Ltd
- 8.3.6.1. Company Overview
- 8.3.6.2. Financial Performance
- 8.3.6.3. Service Benchmarking
- 8.3.6.4. Strategic Initiatives
- 8.3.7. Nidek Co. Ltd.
- 8.3.7.1. Company Overview
- 8.3.7.2. Financial Performance
- 8.3.7.3. Service Benchmarking
- 8.3.7.4. Strategic Initiatives
- 8.3.8. TOPCON CORPORATION
- 8.3.8.1. Company Overview
- 8.3.8.2. Financial Performance
- 8.3.8.3. Service Benchmarking
- 8.3.8.4. Strategic Initiatives
- 8.3.9. Haag-Streit Group
- 8.3.9.1. Company Overview
- 8.3.9.2. Financial Performance
- 8.3.9.3. Service Benchmarking
- 8.3.9.4. Strategic Initiatives
- 8.3.10. Glaukos Corporation
- 8.3.10.1. Company Overview
- 8.3.10.2. Financial Performance
- 8.3.10.3. Service Benchmarking
- 8.3.10.4. Strategic Initiatives